期刊文献+

颅咽管瘤IFN-α囊内化学治疗的现状

Current status of intracystic chemotherapy with IFN-αfor craniopharyngioma
原文传递
导出
摘要 颅咽管瘤(CP)是一种儿童常见的颅脑良性肿瘤。囊内注射药物进行化学治疗是有效的治疗方式,包括放射性同位素、博来霉素以及干扰素(IFN)-α。IFN治疗后的CP患者,相较于传统的药物毒性产生的不良反应更轻微且多是可控的,但进行IFN治疗之前应进行渗漏检查。近十年研究证据表明,IFN-α治疗肿瘤控制程度好,不良反应小,是目前可靠的一种治疗选择,由于在国内缺乏足够的临床证据而未得到广泛的应用,但因其轻微的不良反应,同时能够保证较好的治疗效果,使得其成为替代传统囊内化学治疗药物最有潜力的选择。 Craniopharyngioma(CP)is a common benign brain tumor in children.Intracapsular injection of drugs for chemotherapy is an effective treatment,including radioisotopes,bleomycin and interferon(IFN)-α.Compared with traditional drugs,the adverse reactions of CP patients after IFN treatment are mild and mostly controllable,and leakage examination should be carried out before IFN treatment.According to the research evidence in the past decade,IFN-αis a reliable treatment option with good tumor control and less adverse reactions.It has not been widely used due to the lack of sufficient clinical evidence in China.However,because of its mild adverse reactions and good therapeutic effect,it has become the most potential alternative to traditional intracapsular chemotherapy.
作者 孙恺 费晓炜 贾怡斌 曹垒 Sun Kai;Fei Xiaowei;Jia Yibin;Cao Lei(Department of Neurosurgery,Army Characteristic Medical Center,Chongqing 400042,China;Department of Neurosurgery,The First Affiliated Hospital of Air Force Military Medical University,Xi’an 710032,China;Department of Neurosurgery,Xuzhou Central Hospital,Xuzhou 221009,China)
出处 《中华脑科疾病与康复杂志(电子版)》 2021年第3期175-179,共5页 Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition)
关键词 颅咽管瘤 干扰素 不良反应 囊内化学治疗 Craniopharyngioma Interferon Adverse reaction Intracapsular chemotherapy
  • 相关文献

参考文献1

二级参考文献1

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部